Related Experiment Videos
The dose-rate effect in interstitial brachytherapy: a controversy resolved.
1Center for Radiological Research, College of Physicians & Surgeons of Columbia University, New York, NY 10032.
The British Journal of Radiology
|March 1, 1992
Summary
The dose rate in low-dose-rate interstitial implants significantly impacts treatment outcomes. Radiobiological data suggest dose adjustments are necessary for varying treatment times to optimize tumor control and normal tissue effects.
Area of Science:
- Radiation Oncology
- Medical Physics
- Radiobiology
Background:
- Low-dose-rate interstitial implants operate within a dose rate range of 0.3 to 1.5 Gy/h.
- Debate exists on whether dose rate variations affect clinical outcomes and necessitate adjustments in prescribed dose based on implant treatment time.
- Conflicting recommendations from the Paterson and Paris schools highlight differing approaches to dose prescription concerning treatment duration.
Purpose of the Study:
- To investigate the impact of dose rate variations on clinical results in low-dose-rate interstitial implants.
- To reconcile the differing recommendations from the Paterson and Paris schools regarding dose prescription and treatment time.
- To analyze the radiobiological and dosimetric factors contributing to discrepancies in isoeffect dose recommendations.
Main Methods:
- Review of experimental radiobiological data (in vitro and in vivo) on biological effectiveness at varying dose rates.
- Radiological considerations and model calculations to analyze dose rate variations and their effects.
- Comparison of dosimetric systems and their correlation with tumor volume, dose rate, and clinical outcomes.
Main Results:
- Experimental data indicate significant changes in biological effectiveness across the dose rate range, particularly for normal tissue late effects.
- Disagreement between the Paterson and Paris schools stems from differing clinical endpoints (late effects vs. combined early/late effects).
- Dosimetric system differences (dose rate independent of tumor volume vs. dose rate correlated with tumor volume) contribute to the recommendations' divergence.
Conclusions:
- Dose rate variations in low-dose-rate interstitial implants have a significant impact on biological effectiveness and clinical outcomes.
- The choice of clinical endpoints and the underlying dosimetric system are critical factors influencing dose prescription strategies.
- Understanding these factors is essential for optimizing treatment time and dose to improve tumor control and minimize normal tissue toxicity.